2
Winners in the Bayer’s business game organized “From a Molecule to Medicine”

Winners in the Bayer’s business game organized “From a Molecule to Medicine”

On April 19, 2017 masters of the Institute of Biochemical Technology and Nanotechnology (IBTN) Natalya Bagayeva, Abo Kura Luay, Armyaninova Darya , Irina Erofeyeva , Novikova Anna participated in a business game organized by the pharmaceutical company Bayer "From a Molecule to Medicine" within the Pharma program in Giperkube (Innovative center "Skolkovo"). Following the results of a game research group consisted of Natalya Bagayeva, Abo Kura Luaya and Darya Armyaninova has received the maximum financing for their project and has won the I place! Congratulations!

On April 19, 2017 masters of the Institute of Biochemical Technology and Nanotechnology (IBTN) Natalya Bagayeva, Abo Kura Luay, Armyaninova Darya , Irina Erofeyeva , Novikova Anna participated in a business game organized by the pharmaceutical company Bayer "From a Molecule to Medicine" within the Pharma program in Giperkube (Innovative center "Skolkovo"). Following the results of a game research group consisted of Natalya Bagayeva, Abo Kura Luaya and Darya Armyaninova has received the maximum financing for their project and has won the I place! Congratulations!

Participants of this interesting simulation tried themselfs hand at as employees and heads of the international pharmaceutical company Ygeia, and also – the independent researchers interacting with Ygeia for creating of new drug for treatment of hemophilia.

Under the leadership of experts and the leader, departments of the pharmaceutical company could make decisions appropriately, and researchers could present competently their projects of the developments taking according to the opinion of investors.

Darya Armyaninova, Abo Kura Luay and Natalya Bagayeva investigated alternative biological medicines.

Irina Erofeyeva took part in group of researchers "Oral biological medicines".

Anna Novikova became a part of the international pharmaceutical company Ygeia.

International scientific cooperation View all
12 Dec 2024
From 19 to 23 November 2024, RUDN hosted the III International Scientific Conference ‘For the Sustainable Development of Civilisation: Cooperation, Science, Education, Technology’. The event gathered more than 2000 participants from 72 countries.
64
Main Publications View all
15 Nov 2017
RUDN University scientists publish results of their scientific researches in highly-recognized in whole world and indexed in international databases journals (Web of Science, Scopus ect.). That, of course, corresponds to the high status of the University and its international recognition. Publications of June-September 2017 ( In Journals of categories Q1-Q3)
1931
Similar newsletter View all
25 Aug 2024
Saving Private Customs Officer: RUDN young scientists develop a project of radiation dosimeter token

Every year, RUDN University hosts a competition of student scientific works “Common Start: Let’s Do Science Together.” The university provides scholarships for projects of young scientists and student associations. All developments are practice-oriented and have the potential for further commercialization.

155
11 Jul 2024
A project by young scientists from RUDN University will help preserve rock art using silver nanoparticles

Every year, RUDN University hosts a competition of student scientific works “Common Start: Let’s Do Science Together.” The university provides scholarships for projects of young scientists and student associations. All developments are practice-oriented and have the potential for further commercialization.

175
19 Apr 2024
RUDN medical student from India won the competition of term papers with a study of the features of the diagnosis of liver disease

RUDN hosted the competition "On the Pages of the Coursework". Twenty-five papers were recognised, 16 of them received the highest marks. One of the winners of the competition is Ravuri Priyamsha Lakhana from India (VI year, "Medical Business", Medical Institute). She researched non-alcoholic steatohepatitis and spoke about who is at risk and what is needed for early diagnosis.

208
Similar newsletter View all